NEUROCRINE BIOSCIENCES INC financial statements, including revenue, expenses, profit, and loss
The total revenue of NB3 for the last quarter is 558.73 M EUR, and it's 1.40% higher compared to the previous quarter. The net income of Q3 24 is 116.58 M EUR.